Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD

Name: Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD
Uploaded: 2026-10-27T04:00:00+00:00
Duration: 5 min 42 s
Description: Explore emerging findings from the FIND-CKD trial examining finerenone in patients with chronic kidney disease (CKD) without diabetes according to SGLT2 in

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Finerenone in Patients With FSGS: A FIND-CKD Analysis
Finerenone in Patients With FSGS: A FIND-CKD Analysis
Nephrology
Finerenone in Patients With FSGS: A FIND-CKD Analysis
prof. Hiddo Heerspink
- prof. Hiddo Heerspink
Finerenone in Patients With IgAN: A FIND-CKD Analysis
Finerenone in Patients With IgAN: A FIND-CKD Analysis
Nephrology
Finerenone in Patients With IgAN: A FIND-CKD Analysis
Brendon Neuen, MBBS, PhD
- Brendon Neuen, MBBS, PhD
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart Matters
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD; Payal Kohli, MD, FACC
- Shelina Ramnarine, PhD
- Payal Kohli, MD, FACC
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
On the Frontlines of Osteoporosis
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Ryan Quigley; Charles Ginsberg, MD
- Ryan Quigley
- Charles Ginsberg, MD

Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD

Recommended

NEED HELP?

Contact us

NEED HELP?

Contact us

Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD

Recommended

Title